Artal Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-253,863
| Closed | -$20.8M | – | 126 |
|
2024
Q1 | $20.8M | Buy |
+253,863
| New | +$20.8M | 0.53% | 25 |
|
2023
Q2 | – | Sell |
-300,000
| Closed | -$5M | – | 129 |
|
2023
Q1 | $5M | Buy |
+300,000
| New | +$5M | 0.3% | 62 |
|
2020
Q1 | – | Sell |
-350,000
| Closed | -$2.81M | – | 107 |
|
2019
Q4 | $2.81M | Hold |
350,000
| – | – | 0.11% | 76 |
|
2019
Q3 | $2.41M | Buy |
350,000
+250,000
| +250% | +$1.72M | 0.1% | 80 |
|
2019
Q2 | $830K | Buy |
+100,000
| New | +$830K | 0.03% | 88 |
|